Inhibition of VEGFA and Ang-2 normalizes tumor vessels and increases IFNγ+ CD8+ T cells’ extravasation and accumulation, which further enhances the antitumor effects of PD-1 inhibitors [146,147]. Here, CD8A is linked to neoplasm.